Dublin, California | 31 March 2021 | ZEISS Group
ZEISS, the leading global optics and optoelectronics technology company, has completed construction of its new R&D, production, sales and customer service site in the San Francisco Bay Area. Bringing together hundreds of ZEISS employees and key functions under one roof, represents a major milestone in the company’s international innovation and growth strategy. “The new ZEISS Innovation Center harnesses our technological, research and customer services strengths in one of the world’s premier technology innovation locations,” said Dr. Christian Müller, Chief Financial Officer of the ZEISS Group. “This long-term commitment to the Bay Area and the North American market, strongly supports the development of exciting innovations that benefit our global customers, alongside new collaboration opportunities with our partners across academia, industry and local communities.”
The $180 million investment in the new high-tech site in Dublin, a fast-growing city near San Francisco, Oakland and San Jose, is an integral part of the ZEISS global strategy to expand its presence close to research centers and growth markets. The ZEISS Innovation Center’s R&D efforts will increasingly focus on digital solutions and scientific and industry partnerships spanning disciplines and technologies – key drivers behind the company’s decision to locate the Center in the Bay Area.
The ZEISS Innovation Center houses customer experience and demonstration centers showcasing recent ZEISS innovations, as well as research laboratories, service and production facilities. With engineers, researchers, and sales and service teams from across ZEISS located on the same premises, global customers and partners will be able to more fully benefit from ZEISS’ expertise. The Center also serves as the US headquarters for the ZEISS medical technology business, bundled under the Frankfurt-listed company Carl Zeiss Meditec AG in which ZEISS holds the majority. ZEISS medical technology develops and distributes cutting-edge solutions for ophthalmology and microsurgery worldwide. The investment in the new California site underscores the commitment to developing advanced technologies that improve the quality of life of patients, and that drive progress, efficiency and access in healthcare.
The new site also brings together the X-Ray Microscopy business and the ZEISS Microscopy Customer Center, strengthening initiatives to realize growing market and R&D opportunities in materials research, life sciences and industrial applications. The co-location of the microscopy and ophthalmology businesses offers additional collaborative opportunities, particularly in image processing, machine learning and artificial intelligence.
The ZEISS Process Control Solutions activities for the ZEISS Semiconductor Manufacturing Technology segment is also based at the Center.
The opening of the ZEISS Innovation Center coincides with the 175th anniversary of the ZEISS Group, which was founded in 1846 in Jena, Germany. Commemoration initiatives will spotlight the company’s long-held commitment to open, unbiased and science-based problem-solving leading to breakthrough technologies that benefit current and future generations. In that spirit, the Innovation Center is designed to foster entrepreneurial ventures among ZEISS employees, research partners and customers in a state-of-the-art open, team-oriented work environment.
ZEISS has been expanding and modernizing sites in the United States, Germany, Europe and Asia in recent years to fully leverage the potential of those markets. In January 2020, ZEISS began operating the ZEISS Innovation Hub at the Karlsruhe Institute of Technology (KIT) in Karlsruhe, Germany. The Innovation Hub promotes scientific and technology collaborations and start-up ventures. An additional high-tech site is under construction in Jena, Germany.
In line with its strong technology track record, the ZEISS Innovation Center in Dublin meets the highest green energy and sustainability standards. The building is powered by solar energy, supported by use-based light and air controls and a heat recovery system. Sophisticated light and insulation technologies help regulate the indoor temperature.
Bioretention areas*, along with wetland enhancement and maintenance, are incorporated into the exterior design. To support commutes and help reduce traffic congestion and pollution, employees will have access to electric vehicle chargers, bike storage, and carpool options.
The Center accommodates approximately 700 workspaces and the move-in will be phased over coming months in compliance with COVID-19 precautions and state and federal regulations.
Further information at: www.zeiss.com/innovationcenter
* Correction on March 28, 2022: This press release differs from the first publication.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2020).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With over 32,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com